T

Tahoe Therapeutics

AI-powered in vivo drug discovery platform

Senior Machine Learning Engineer

Applied Machine LearningConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USANo salary listed

About the Job

Requirements

  • Solid engineering and computer science fundamentals, ideally supported by a degree in Computer Science or Mathematics, or equivalent experience.
  • Exceptional engineering skills to iterate quickly on data processing and training pipelines.
  • Experience building, testing, training, and deploying modern neural network architectures such as Transformers.
  • Experience with frameworks such as PyTorch, TensorFlow, Keras, or JAX, and ability to write hardware-optimized code for distributed training.

Responsibilities

  • Stay at the forefront of machine learning and computational biology research and rapidly adopt state-of-the-art techniques to train AI virtual cell models on massive single-cell datasets.
  • Work together with Machine Learning Scientists to develop the next generation of compute-optimized models such as Tahoe-x1.

Desired Qualifications

  • Experience with distributed deep learning using frameworks such as Hugging Face Accelerate, DeepSpeed, Composer, TorchTitan, or Megatron.
  • Experience training large neural networks on multiple compute nodes.

About the Company

Tahoe Therapeutics

AI-powered in vivo drug discovery platform

Tahoe Therapeutics engineers AI-powered models of human cells to improve drug design, focusing on cancer targets in the RAS network. Its Mosaic platform creates in vivo, single-cell perturbation data by pooling cells from hundreds of diverse patient models in a single experiment, such as a mosaic tumor in a mouse, generating large-scale datasets like Tahoe-100M with 100 million data points and 60,000 drug–cell interactions to train AI models. This approach captures disease and drug-response heterogeneity better than standard preclinical tests and provides a more direct view of human biology. The company aims to advance internal programs toward clinical trials and form partnerships to share larger datasets to accelerate medicine discovery and AI model development, including a 2026 joint venture with Alloy Therapeutics for antibody-drug conjugates, with an initial emphasis on oncology and the RAS pathway.

Company size
11-50
Company stage
Series A
Total funding
$42M
Headquarters
South San Francisco, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Tahoe Therapeutics

See more jobs